Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N
4506.T - Sumitomo Pharma Co Ltd
Q1 2027 Sumitomo Pharma Co Ltd Earnings Presentation
Jul 31, 2026 / NTS GMT
=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
We will now begin Sumitomo Pharma's financial results briefing for Q1 FY 2026.
I would like to introduce today's speakers: Sakai, Representative Director and Executive Vice President Nakagawa, Member, Board of Directors and Managing Executive Officer Sato, Managing Executive Officer and Wakemi, Executive Officer.
Sakai will now provide an overview of the financial results for Q1 FY 2026 and the current status of clinical development.
Mr. Sakai, please proceed.
This is Sakai from Sumitomo Pharma.
Thank you for joining us today.
First, we would like to express our sincere sympathy to all those affected by the Lewa 8 Kumamoto earthquake that occurred on July 28, 2026. And
Trustpilot
